OraSure Technologies Inc. Registered Shares o.N.
- BID
3.42
- ASK
3.5
- 7,314 Units8,581 Units
- 07/22, 11:53:39 AM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
20.29%
Market Cap
402.85 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.83 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.42 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 11:32:40 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 3.42 | 3.34 |
| PREV. DAY'S PRICE | 3.32 | (07/21) |
| CHANGE DAY BEFORE | +0.10 | 3.01 % |
| 52 WEEK HIGH / LOW | 3.94 (06/18) | 1.82 (11/19) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.67 | -0.24 | -0.83 | -0.92 | -0.72 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 11.37 | - | - | - | - |
PRICE - BOOK RATIO | 1.40 | 0.66 | 0.50 | - | - |
PRICE - SALES RATIO | 1.50 | 1.45 | 1.55 | - | - |
PRICE - CASH FLOW RATIO | 4.31 | 9.82 | - | - | - |
Master Data
| WKN | 881351 |
| ISIN | US68554V1089 |
| SYMBOL | EP3 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Orasure Technologies |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 73.80 Mil. |
| MARKET CAPITALISATION | 402.85 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -11.23 % | -9.78 % | 23.88 % | 39.50 % | 20.29 % | -17.82 % | -62.41 % | 61.17 % |
| HIGH | 3.76 | 3.94 | 3.94 | 3.94 | 3.94 | 7.55 | 11.33 | 3.94 |
| LOW | 3.24 | 3.24 | 2.44 | 2.18 | 1.82 | 1.82 | 1.82 | 1.98 |
Dividende
pro Aktie
Orasure Technologies does not deliver dividend information
Company profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.